Search
Learn about
Our Products
Ecosystems
Portfolios
Due Diligence
Funder Prospecting
Log in
Start
for Free
HUMAN VACCINES PROJECT INC
Sign up to claim this org
HUMAN VACCINES PROJECT INC
New York, NY, US
•
501(c)3
•
EIN
47-2364966
•
WWW.HUMANVACCINESPROJECT.ORG
•
Research Institutes & Public Policy Analysis
Regional Funder
HUMAN VACCINES PROJECT INC
Sign up to claim this org
New York, NY, US
•
501(c)3
•
EIN
47-2364966
•
WWW.HUMANVACCINESPROJECT.ORG
•
Research Institutes & Public Policy Analysis
Regional Funder
Overview
Programs
990s
Income Statement
Balance Sheet
How to Apply
Sign up
for more:
People
Board & Team
Financials
Financial Trends
Funding
Funders
Grants Received
Grantmaking
Giving Insights
Grantees
Grants Given
Overlap
Hide details
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in
2024
(Year End)
$1,745,859
Cash & Equivalents
99%
Prepaid Expenses
1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in
2024
(Year End)
$341,282
Deferred Revenue
56%
Payables & Accruals
44%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,738,188
$1,723,857
-1%
Receivables (Non-Related)
$1,000,543
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$4,971
$22,002
+343%
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
$156,120
-
-
Total Assets
$2,899,822
$1,745,859
-40%
Liabilities
2023
2024
Change
Payables & Accruals
$136,991
$150,885
+10%
Grants Payable
$867,699
-
-
Deferred Revenue
-
$190,397
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$1,004,690
$341,282
-66%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$1,895,132
$1,404,577
-26%
Net assets
2023
2024
Change
Net assets
+$1,895,132
+$1,404,577
-26%
Balance Sheet
